首页> 外文期刊>ACS applied materials & interfaces >Responsive Prodrug Self-Assembled Vesicles for Targeted Chemotherapy in Combination with Intracellular Imaging
【24h】

Responsive Prodrug Self-Assembled Vesicles for Targeted Chemotherapy in Combination with Intracellular Imaging

机译:反应性前药自组装囊泡与细胞内成像相结合的靶向化疗。

获取原文
获取原文并翻译 | 示例
       

摘要

Targeted drug delivery systems having controlled drug release property with an inherent fluorescence reporter have drawn a lot of attention-in nanomedicine. However, only very few prodrugs can be directly Used to construct such delivery systems. Herein, we report that an amphiphilic chlorambucil-based prodrug consisting of a fluorescence reporter and a D-mannose targeting ligand could directly self-assemble into glutathione-responsive nanovesicles for selective cancer therapy and intracellular imaging. These nanovesicles could be dissociated to release the chlorambucil drug :with obviously red-shifted fluorescence when internalized by D-mannose receptor-overexpressed MCF-7 cancer cells. in addition, the nanovesicles displayed better selectivity and higher therapy efficiency than free chlorambucil drug.
机译:具有内在的荧光报告物的具有受控的药物释放特性的靶向药物递送系统已经引起了纳米医学的广泛关注。但是,只有极少数的前药可以直接用于构建此类递送系统。在此,我们报道了由荧光报告基因和D-甘露糖靶向配体组成的两亲基于苯丁酸氮芥的前药可以直接自组装成谷胱甘肽反应性纳米囊泡,用于选择性癌症治疗和细胞内成像。这些纳米囊泡可以解离释放苯丁酸氮芥药物:当被D-甘露糖受体过度表达的MCF-7癌细胞内化时,具有明显的红移荧光。此外,纳米囊泡比游离苯丁酸氮芥药物显示出更好的选择性和更高的治疗效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号